Literature DB >> 26194583

Chemical databases: curation or integration by user-defined equivalence?

Anne Hersey1, Jon Chambers2, Louisa Bellis2, A Patrícia Bento2, Anna Gaulton2, John P Overington2.   

Abstract

There is a wealth of valuable chemical information in publicly available databases for use by scientists undertaking drug discovery. However finite curation resource, limitations of chemical structure software and differences in individual database applications mean that exact chemical structure equivalence between databases is unlikely to ever be a reality. The ability to identify compound equivalence has been made significantly easier by the use of the International Chemical Identifier (InChI), a non-proprietary line-notation for describing a chemical structure. More importantly, advances in methods to identify compounds that are the same at various levels of similarity, such as those containing the same parent component or having the same connectivity, are now enabling related compounds to be linked between databases where the structure matches are not exact.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26194583      PMCID: PMC6294287          DOI: 10.1016/j.ddtec.2015.01.005

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  15 in total

Review 1.  Open PHACTS: semantic interoperability for drug discovery.

Authors:  Antony J Williams; Lee Harland; Paul Groth; Stephen Pettifer; Christine Chichester; Egon L Willighagen; Chris T Evelo; Niklas Blomberg; Gerhard Ecker; Carole Goble; Barend Mons
Journal:  Drug Discov Today       Date:  2012-06-07       Impact factor: 7.851

2.  Tautomerism in chemical information management systems.

Authors:  Wendy A Warr
Journal:  J Comput Aided Mol Des       Date:  2010-04-06       Impact factor: 3.686

3.  Estimating error rates in bioactivity databases.

Authors:  Pekka Tiikkainen; Louisa Bellis; Yvonne Light; Lutz Franke
Journal:  J Chem Inf Model       Date:  2013-10-02       Impact factor: 4.956

4.  Open data for drug discovery: learning from the biological community.

Authors:  Anne Hersey; Stefan Senger; John P Overington
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

5.  Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research.

Authors:  Denis Fourches; Eugene Muratov; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2010-07-26       Impact factor: 4.956

6.  Tautomerism in large databases.

Authors:  Markus Sitzmann; Wolf-Dietrich Ihlenfeldt; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2010-05-29       Impact factor: 3.686

7.  DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.

Authors:  Craig Knox; Vivian Law; Timothy Jewison; Philip Liu; Son Ly; Alex Frolkis; Allison Pon; Kelly Banco; Christine Mak; Vanessa Neveu; Yannick Djoumbou; Roman Eisner; An Chi Guo; David S Wishart
Journal:  Nucleic Acids Res       Date:  2010-11-08       Impact factor: 16.971

8.  The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013.

Authors:  Janna Hastings; Paula de Matos; Adriano Dekker; Marcus Ennis; Bhavana Harsha; Namrata Kale; Venkatesh Muthukrishnan; Gareth Owen; Steve Turner; Mark Williams; Christoph Steinbeck
Journal:  Nucleic Acids Res       Date:  2012-11-24       Impact factor: 16.971

9.  UniChem: a unified chemical structure cross-referencing and identifier tracking system.

Authors:  Jon Chambers; Mark Davies; Anna Gaulton; Anne Hersey; Sameer Velankar; Robert Petryszak; Janna Hastings; Louisa Bellis; Shaun McGlinchey; John P Overington
Journal:  J Cheminform       Date:  2013-01-14       Impact factor: 5.514

10.  PDBe: Protein Data Bank in Europe.

Authors:  Aleksandras Gutmanas; Younes Alhroub; Gary M Battle; John M Berrisford; Estelle Bochet; Matthew J Conroy; Jose M Dana; Manuel A Fernandez Montecelo; Glen van Ginkel; Swanand P Gore; Pauline Haslam; Rowan Hatherley; Pieter M S Hendrickx; Miriam Hirshberg; Ingvar Lagerstedt; Saqib Mir; Abhik Mukhopadhyay; Thomas J Oldfield; Ardan Patwardhan; Luana Rinaldi; Gaurav Sahni; Eduardo Sanz-García; Sanchayita Sen; Robert A Slowley; Sameer Velankar; Michael E Wainwright; Gerard J Kleywegt
Journal:  Nucleic Acids Res       Date:  2013-11-27       Impact factor: 16.971

View more
  14 in total

1.  Many InChIs and quite some feat.

Authors:  Wendy A Warr
Journal:  J Comput Aided Mol Des       Date:  2015-06-17       Impact factor: 3.686

2.  Computational Prediction of Chemical Tools for Identification and Validation of Synthetic Lethal Interaction Networks.

Authors:  Kalpana K Bhanumathy; Omar Abuhussein; Frederick S Vizeacoumar; Andrew Freywald; Franco J Vizeacoumar; Christopher P Phenix; Eric W Price; Ran Cao
Journal:  Methods Mol Biol       Date:  2021

3.  Activity, assay and target data curation and quality in the ChEMBL database.

Authors:  George Papadatos; Anna Gaulton; Anne Hersey; John P Overington
Journal:  J Comput Aided Mol Des       Date:  2015-07-23       Impact factor: 3.686

4.  Systematic integration of biomedical knowledge prioritizes drugs for repurposing.

Authors:  Daniel Scott Himmelstein; Antoine Lizee; Christine Hessler; Leo Brueggeman; Sabrina L Chen; Dexter Hadley; Ari Green; Pouya Khankhanian; Sergio E Baranzini
Journal:  Elife       Date:  2017-09-22       Impact factor: 8.140

5.  Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.

Authors:  Jing Tang; Zia-Ur-Rehman Tanoli; Balaguru Ravikumar; Zaid Alam; Anni Rebane; Markus Vähä-Koskela; Gopal Peddinti; Arjan J van Adrichem; Janica Wakkinen; Alok Jaiswal; Ella Karjalainen; Prson Gautam; Liye He; Elina Parri; Suleiman Khan; Abhishekh Gupta; Mehreen Ali; Laxman Yetukuri; Anna-Lena Gustavsson; Brinton Seashore-Ludlow; Anne Hersey; Andrew R Leach; John P Overington; Gretchen Repasky; Krister Wennerberg; Tero Aittokallio
Journal:  Cell Chem Biol       Date:  2017-12-21       Impact factor: 8.116

6.  Novel phosphatidylinositol 4-kinases III beta (PI4KIIIβ) inhibitors discovered by virtual screening using free energy models.

Authors:  Natalie M Colodette; Lucas S Franco; Rodolfo C Maia; Harold H Fokoue; Carlos Mauricio R Sant'Anna; Eliezer J Barreiro
Journal:  J Comput Aided Mol Des       Date:  2020-06-30       Impact factor: 3.686

7.  Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles.

Authors:  ZiaurRehman Tanoli; Zaid Alam; Markus Vähä-Koskela; Balaguru Ravikumar; Alina Malyutina; Alok Jaiswal; Jing Tang; Krister Wennerberg; Tero Aittokallio
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

8.  Patterns of database citation in articles and patents indicate long-term scientific and industry value of biological data resources.

Authors:  David Bousfield; Johanna McEntyre; Sameer Velankar; George Papadatos; Alex Bateman; Guy Cochrane; Jee-Hyub Kim; Florian Graef; Vid Vartak; Blaise Alako; Niklas Blomberg
Journal:  F1000Res       Date:  2016-02-11

9.  VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization.

Authors:  Bence Bolgár; Péter Antal
Journal:  BMC Bioinformatics       Date:  2017-10-04       Impact factor: 3.169

10.  Integration among databases and data sets to support productive nanotechnology: Challenges and recommendations.

Authors:  Sandra Karcher; Egon L Willighagen; John Rumble; Friederike Ehrhart; Chris T Evelo; Martin Fritts; Sharon Gaheen; Stacey L Harper; Mark D Hoover; Nina Jeliazkova; Nastassja Lewinski; Richard L Marchese Robinson; Karmann C Mills; Axel P Mustad; Dennis G Thomas; Georgia Tsiliki; Christine Ogilvie Hendren
Journal:  NanoImpact       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.